# Glucocorticoid Antagonist Treatment for Tobacco Use Disorder

> **NCT03248713** · EARLY_PHASE1 · TERMINATED · sponsor: **Yale University** · enrollment: 8 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03248713
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-29
- **Primary completion:** 2019-05-20
- **Final completion:** 2019-05-20
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03248713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03248713, "Glucocorticoid Antagonist Treatment for Tobacco Use Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03248713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*